Literature DB >> 32853343

Ultra-High Dose-Rate, Pulsed (FLASH) Radiotherapy with Carbon Ions: Generation of Early, Transient, Highly Oxygenated Conditions in the Tumor Environment.

Abdullah Muhammad Zakaria1, Nicholas W Colangelo2, Jintana Meesungnoen1, Edouard I Azzam2, Marc-Émile Plourde1, Jean-Paul Jay-Gerin1.   

Abstract

It is well known that molecular oxygen is a product of the radiolysis of water with high-linear energy transfer (LET) radiation, which is distinct from low-LET radiation wherein O2 radiolytic yield is negligible. Since O2 is a powerful radiosensitizer, this fact is of practical relevance in cancer therapy with energetic heavy ions, such as carbon ions. It has recently been discovered that large doses of ionizing radiation delivered to tumors at very high dose rates (i.e., in a few milliseconds) have remarkable benefits in sparing healthy tissue while preserving anti-tumor activity compared to radiotherapy delivered at conventional, lower dose rates. This new method is called "FLASH radiotherapy" and has been tested using low-LET radiation (i.e., electrons and photons) in various pre-clinical studies and recently in a human patient. Although the exact mechanism(s) underlying FLASH are still unclear, it has been suggested that radiation delivered at high dose rates spares normal tissue via oxygen depletion. In addition, heavy-ion radiation achieves tumor control with reduced normal tissue toxicity due to its favorable physical depth-dose profile and increased radiobiological effectiveness in the Bragg peak region. To date, however, biological research with energetic heavy ions delivered at ultra-high dose rates has not been performed and it is not known whether heavy ions are suitable for FLASH radiotherapy. Here we present the additive or even synergistic advantages of integrating the FLASH dose rates into carbon-ion therapy. These benefits result from the ability of heavy ions at high LET to generate an oxygenated microenvironment around their track due to the occurrence of multiple (mainly double) ionization of water. This oxygen is abundant immediately in the tumor region where the LET of the carbon ions is very high, near the end of the carbon-ion path (i.e., in the Bragg peak region). In contrast, in the "plateau" region of the depth-dose distribution of ions (i.e., in the normal tissue region), in which the LET is significantly lower, this generation of molecular oxygen is insignificant. Under FLASH irradiation, it is shown that this early generation of O2 extends evenly over the entire irradiated tumor volume, with concentrations estimated to be several orders of magnitude higher than the oxygen levels present in hypoxic tumor cells. Theoretically, these results indicate that FLASH radiotherapy using carbon ions would have a markedly improved therapeutic ratio with greater toxicity in the tumor due to the generation of oxygen at the spread-out Bragg peak. ©2020 by Radiation Research Society. All rights of reproduction in any form reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32853343      PMCID: PMC7856087          DOI: 10.1667/RADE-19-00015.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  22 in total

1.  A computational model of radiolytic oxygen depletion during FLASH irradiation and its effect on the oxygen enhancement ratio.

Authors:  Guillem Pratx; Daniel S Kapp
Journal:  Phys Med Biol       Date:  2019-09-11       Impact factor: 3.609

2.  Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species.

Authors:  Pierre Montay-Gruel; Munjal M Acharya; Kristoffer Petersson; Leila Alikhani; Chakradhar Yakkala; Barrett D Allen; Jonathan Ollivier; Benoit Petit; Patrik Gonçalves Jorge; Amber R Syage; Thuan A Nguyen; Al Anoud D Baddour; Celine Lu; Paramvir Singh; Raphael Moeckli; François Bochud; Jean-François Germond; Pascal Froidevaux; Claude Bailat; Jean Bourhis; Marie-Catherine Vozenin; Charles L Limoli
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-16       Impact factor: 11.205

3.  High-LET radiolysis of liquid water with 1H+, 4He2+, 12C6+, and 20Ne9+ ions: effects of multiple ionization.

Authors:  Jintana Meesungnoen; Jean-Paul Jay-Gerin
Journal:  J Phys Chem A       Date:  2005-07-28       Impact factor: 2.781

Review 4.  Irradiation of cells by single and double pulses of high intensity radiation: oxygen sensitization and diffusion kinetics.

Authors:  E R Epp; H Weiss; C C Ling
Journal:  Curr Top Radiat Res Q       Date:  1976-12

5.  Estimation of oxygen distribution in RIF-1 tumors by diffusion model-based interpretation of pimonidazole hypoxia and eppendorf measurements.

Authors:  B W Pogue; K D Paulsen; J A O'Hara; C M Wilmot; H M Swartz
Journal:  Radiat Res       Date:  2001-01       Impact factor: 2.841

Review 6.  Radiation oncology: a century of achievements.

Authors:  Jacques Bernier; Eric J Hall; Amato Giaccia
Journal:  Nat Rev Cancer       Date:  2004-09       Impact factor: 60.716

7.  High-LET ion radiolysis of water: oxygen production in tracks.

Authors:  Jintana Meesungnoen; Jean-Paul Jay-Gerin
Journal:  Radiat Res       Date:  2009-03       Impact factor: 2.841

8.  The Importance and Clinical Implications of FLASH Ultra-High Dose-Rate Studies for Proton and Heavy Ion Radiotherapy.

Authors:  Nicholas W Colangelo; Edouard I Azzam
Journal:  Radiat Res       Date:  2019-10-28       Impact factor: 2.841

Review 9.  Carbon Ion Radiotherapy: A Review of Clinical Experiences and Preclinical Research, with an Emphasis on DNA Damage/Repair.

Authors:  Osama Mohamad; Brock J Sishc; Janapriya Saha; Arnold Pompos; Asal Rahimi; Michael D Story; Anthony J Davis; D W Nathan Kim
Journal:  Cancers (Basel)       Date:  2017-06-09       Impact factor: 6.639

10.  The Emerging Role of Carbon-Ion Radiotherapy.

Authors:  Daniel K Ebner; Tadashi Kamada
Journal:  Front Oncol       Date:  2016-06-07       Impact factor: 6.244

View more
  7 in total

Review 1.  Role of Mitochondria in Radiation Responses: Epigenetic, Metabolic, and Signaling Impacts.

Authors:  Dietrich Averbeck; Claire Rodriguez-Lafrasse
Journal:  Int J Mol Sci       Date:  2021-10-13       Impact factor: 5.923

2.  Development of Ultra-High Dose-Rate (FLASH) Particle Therapy.

Authors:  Michele M Kim; Arash Darafsheh; Jan Schuemann; Ivana Dokic; Olle Lundh; Tianyu Zhao; José Ramos-Méndez; Lei Dong; Kristoffer Petersson
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2021-06-22

Review 3.  Emerging Role of Carbon Ion Radiotherapy in Reirradiation of Recurrent Head and Neck Cancers: What Have We Achieved So Far?

Authors:  Tapesh Bhattacharyya; Masashi Koto; Paul Windisch; Hiroaki Ikawa; Yasuhito Hagiwara; Hiroshi Tsuji; Sebastian Adeberg
Journal:  Front Oncol       Date:  2022-05-23       Impact factor: 5.738

4.  Physics and biomedical challenges of cancer therapy with accelerated heavy ions.

Authors:  Marco Durante; Jürgen Debus; Jay S Loeffler
Journal:  Nat Rev Phys       Date:  2021-09-17

Review 5.  Carbon Ion Radiobiology.

Authors:  Walter Tinganelli; Marco Durante
Journal:  Cancers (Basel)       Date:  2020-10-17       Impact factor: 6.575

6.  Hyperbaric Oxygen Therapy as a Complementary Treatment in Glioblastoma-A Scoping Review.

Authors:  Diogo Alpuim Costa; Mafalda Sampaio-Alves; Eduardo Netto; Gonçalo Fernandez; Edson Oliveira; Andreia Teixeira; Pedro Modas Daniel; Guilherme Silva Bernardo; Carla Amaro
Journal:  Front Neurol       Date:  2022-07-01       Impact factor: 4.086

Review 7.  Future Developments in Charged Particle Therapy: Improving Beam Delivery for Efficiency and Efficacy.

Authors:  Jacinta Yap; Andrea De Franco; Suzie Sheehy
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.